本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mesoblast Limited

16.88
-0.0300-0.18%
盤後16.910.0300+0.18%19:37 EST
成交量:16.84萬
成交額:283.60萬
市值:21.66億
市盈率:-19.95
高:16.98
開:16.89
低:16.70
收:16.91
52周最高:21.50
52周最低:9.61
股本:1.28億
流通股本:7,864.91萬
量比:1.02
換手率:0.21%
股息:- -
股息率:- -
每股收益(TTM):-0.8460
每股收益(LYR):-0.8457
淨資產收益率:-18.95%
總資產收益率:-5.37%
市淨率:3.62
市盈率(LYR):-19.96

資料載入中...

公司資料

公司名字:
Mesoblast Limited
交易所:
NASDAQ
成立時間:
2004
員工人數:
81
公司地址:
55 Collins Street,Level 38,Melbourne,Victoria,Australia
郵編:
3000
傳真:
61 3 9639 6030
簡介:
Mesoblast Limited於2004年6月8日在澳大利亞成立。該公司在開發同種異體細胞藥物方面處於世界領先地位。該公司利用其專有的間充質譜系細胞治療技術平台建立了廣泛的商業產品和後期產品候選產品組合。

董事

名稱
職位
Silviu Itescu
Chief Executive Officer and Executive Director
Eric Rose
Chief Medical Officer and Executive Director
Jane Bell
Independent Chair of Board

股東

名稱
職位
Paul Simmons
Scientific Advisor to the Chief Executive Officer
Silviu Itescu
Chief Executive Officer and Executive Director
Andrew Chaponnel
Chief Financial Officer
Eric Rose
Chief Medical Officer and Executive Director
Fiona See
Head of Translational Research
Geraldine Storton
Head of Regulatory Affairs and Quality Management
Gregory George
Non-Executive Member of the Board
Joseph Swedish
Non-Executive Member of the Board
Justin Horst
Head of Manufacturing
Lyn Cobley
Non-Executive Member of the Board
Michael Schuster
Pharma Partnering
Niva Sivakumar
Joint Company Secretary
Paul Hughes
Joint Company Secretary
Peter Howard
Group General Counsel and Corporate Executive
Philip Facchina
Non-Executive Member of the Board
Philip Krause
Non-Executive Member of the Board
William Burns
Non-Executive Member of the Board